Isabel Garau
Hospital Son Llatzer · 61 works · 1,170 citations · h-index 17
Top works
- Variation in ‘standard care’ for breast cancer across Europe: A EUROCARE-3 high resolution study
- Influence of stage at diagnosis on survival differences for rectal cancer in three European populations
- Recent Changes in Breast Cancer Incidence in Spain, 1980–2004
- Extended adjuvant intermittent letrozole versus continuous letrozole in postmenopausal women with breast cancer (SOLE): a multicentre, open-label, randomised, phase 3 trial
- Comparability of colorectal cancer survival data in three European population-based registries.
- Attenuation of the epidemic increase in non-Hodgkin's lymphomas in Spain
- A predictive model of pathologic response based on tumor cellularity and tumor-infiltrating lymphocytes (CelTIL) in HER2-positive breast cancer treated with chemo-free dual HER2 blockade
- Blood transfusion has no effect on colorectal cancer survival. A population-based study
- Palbociclib and Trastuzumab in HER2-Positive Advanced Breast Cancer: Results from the Phase II SOLTI-1303 PATRICIA Trial
- Estrogen down-regulates uncoupling proteins and increases oxidative stress in breast cancer
- Phenotypic changes of HER2-positive breast cancer during and after dual HER2 blockade
- Final results of the double-blind placebo-controlled randomized phase 2 LOTUS trial of first-line ipatasertib plus paclitaxel for inoperable locally advanced/metastatic triple-negative breast cancer
- Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain
- Actitudes de los trabajadores frente a los programas de promoción de la salud para la prevención del cáncer en el lugar del trabajo
- Incidencia y mortalidad por cáncer en España. Patrones y tendencia
- Immune microenvironment characterisation and dynamics during anti-HER2-based neoadjuvant treatment in HER2-positive breast cancer
- Mejoría de la supervivencia de la poliposis adenomatosa familiar después del establecimiento de un registro
- Assessment of Feasibility of Workplace Health Promotion
- Abstract PD3-03: SOLTI-1303 PATRICIA phase II trial (STAGE 1) -- Palbociclib and trastuzumab in postmenopausal patients with HER2-positive metastatic breast cancer
- Phase II, Multicenter, Single-arm Trial of Eribulin as First-line Therapy for Patients With Aggressive Taxane-pretreated HER2-Negative Metastatic Breast Cancer: The MERIBEL Study